We Shall Not Be Cowed
cancer 'cure' hawker threatens lawsuits
- The Cho Group Ltd, which says its drug cures cancer, wants us to delete our article that questioned that claim
- Through an Australian branch of global law firm, Jones Day, the company says our statements cannot be proven. The company has warned uSpiked of lawsuits in multiple jurisdiction for questioning its fraudulent claims
- Could the choice of Jones Day, a firm that has advertised its close ties to Donald Trump’s Administration, a calculated move to keep various US Federal Agencies off their scheme?
- We stand by our published and we will not be taking it down
- Our only apology is to the cancer patients and investors for not warning them sooner about Photosoft and The Cho Group
- To the victims (patients and investors) who have heeded our call, we shall not give up on you
The Cho Group Ltd, a Hong Kong registered company, is threatening uSpiked and its editor with lawsuits in response to an article that questioned the efficacy of a cancer drug.
It wasn’t just the issue of efficacy that concerned us, but the false hope they peddled to desperate and vulnerable cancer patients.
Through the Australian branch of a global law firm Jones Day, The Cho Group and its subsidiary RMW Cho Group Pty Ltd. is demanding we remove the article from our website.
Our article disputed claims by The Cho Group that its concoction, Photosoft and Next Generation Photodynamic Therapy, cures cancer. In the article, we appealed to cancer patients and investors associated with Photosoft to join our quest for the truth.
Lawyer Brett Heading, in an unsigned emailed to uSpiked on behalf of The Cho Group wrote: “Our clients demand that you remove the article from uSpiked’s website, and confirm to us in writing that you have done so, by 8.00pm Australian Eastern Standard Time today (May 19, 2017).”
Heading claims our article has statements that are 'entirely unsubstantiated and lack any proper factual basis'.
"They are clearly and blatantly defamatory and are calculated to cause significant detriment to our clients’ businesses by deterring customers from dealing with our clients and undermining our clients’ high regard and reputation in the market.”
uSpiked stands by the story. We (and several journalists in four continents) have believable circumstantial evidence that Photosoft is a scam. Photosoft, as claimed in its patent documents and as is currently administered, can't cure cancer and we cannot be sorry for letting the public know that fact.
Michael Honsue Cho, the chairman and major shareholder of The Cho Group, appears to have many tentacles in business. He once invented a multi-layered wine barrel, which few winemakers bothered to buy.
Cho and his companies have every right to view cancer patients as cash cows. But, we won't be cowed by threats meant to distract us from the task at hand. We will continue to demand due protection for the vulnerable cancer patients from peddlers of fake cures.
The Brisbane office of Jones Day focuses on mergers and acquisitions in natural resources, construction, transport and agriculture sectors, according to launch statements made in February 2016. It is interesting that this particular Jones Day’s branch is acting on behalf of Cho and Companies in defence of a scheme targeting cancer patients. More on this including how Honsue Cho ended up with a Brisbane outfit to follow in the coming weeks…
The decision to go with Jones Day, a firm that has unashamedly advertised its ties with Donald Trump’s White House, has not escaped uSpiked and Team. Could it be a strategic move to shield Honsue Cho and his companies against possible investigations by the US Justice Department under Foreign Corrupt Practices Act should it be proven that some of their victims paid in US dollars? Or even the FDA from investigating them for providing fake cures for cancer?
Our message to Michael Honsue Cho is this: "You may have the resources to seek an injunction or for attempts to shut us down, but we will get to the truth about your scheme soon no matter the barriers you may erect."
To the learned fellow, Brett Heading, next time you want your aimless letters to have some legal force, please try and append your signature to them.
Below is Heading’s letter in full delivered on the morning of May 19, 2017 as an email attachment.
Dear Mr Thomas,
The Cho Group Ltd, RMW Cho Group Pty Ltd, Next Generation PDT and Photosoft – publication of defamatory material
We act for The Cho Group Ltd and RMW Cho Group Pty Ltd.
We write on behalf of our clients in relation to the article ‘Cancer Profiteers: Are You a Victim of This Cancer Scam?’, published on uSpiked’s website on 14 May 2017, which you authored in your capacity as editor-in-chief of uSpiked.
In your article, you:
- label Cho Group Ltd a ‘predator’;
- state that the Next Generation PDT and Photosoft treatments manufactured and promoted by both of our clients are akin to ‘Barry Tannenbaum and American Bernie Madoff schemes’, with all of the fraudulent and exploitative connotations that such an analogy infers;
- suggest that our clients are somehow seeking to abuse ‘millions of desperate and vulnerable cancer patients’ by advocating for ‘snake oil’ treatments which amount to a ‘scam’; and
- encourage customers of our clients to stop dealing with our clients so they can avoid being ‘victims’.
Your statements (both express and implied) are entirely unsubstantiated and lack any proper factual basis. They are clearly and blatantly defamatory and are calculated to cause significant detriment to our clients’ businesses by deterring customers from dealing with our clients and undermining our clients’ high regard and reputation in the market.
The publication of the article entitles our clients to seek an injunction and both general and aggravated damages against you and uSpiked in each jurisdiction in which the article has been accessed worldwide.
Our clients demand that you remove the article from uSpiked’s website, and confirm to us in writing that you have done so, by 8.00pm Australian Eastern Standard Time today.
If you fail to remove the article by that time, we are instructed that our clients intend to immediately institute legal proceedings compelling you to do so.
While your removal of the article may limit the accumulation of any further damages, our clients reserve the right to commence proceedings against you and uSpiked for the damage that has already accrued as a result of the publication of the article and will continue to accrue until the article is removed.
The Letter as was emailed to the attention of uSpiked’s Editor and copied to our Ombudsman.